RALEIGH, N.C.--(BUSINESS WIRE)--BioDelivery Sciences International, Inc. (Nasdaq: BDSI), a specialty pharmaceutical company focused on developing innovative products to address growing market opportunities using its proprietary drug delivery technologies, today announced that Mark A. Sirgo, Pharm.D., President and Chief Executive Officer, will present at the upcoming Cowen and Company 29th Annual Health Care Conference.
